Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment - ScienceDirect
Synergistic Effect of CTLA-4 Blockade and Cancer Chemotherapy in the Induction of Anti-Tumor Immunity | PLOS ONE
Anti-mCTLA4 Monoclonal Antibody | Murine Recombinant 9D9
Molecules | Free Full-Text | Molecular Interactions of Antibody Drugs Targeting PD-1, PD-L1, and CTLA-4 in Immuno-Oncology | HTML
Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response - ScienceDirect
Localized low-dose anti-CTLa4 antibody therapy is efficacious. (A-C)... | Download Scientific Diagram
Response to anti-CTLA-4 immunotherapy Day 16 post-YUMMER1.7... | Download Scientific Diagram
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy | Cell Research
T-cell activation by anti-CTLA-4 antibodies. Notes: (A) Tumor antigens... | Download Scientific Diagram
Inhibitors of immune checkpoints—PD-1, PD-L1, CTLA-4—new opportunities for cancer patients and a new challenge for internists and general practitioners | SpringerLink
800 Dual targeting of CTLA-4 and CD47 on Treg cells rejuvenates immunity against solid tumors | Journal for ImmunoTherapy of Cancer
Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action - Willsmore - 2021 - European Journal of Immunology - Wiley Online Library
Anti-CTLA-4 therapy for malignant mesothelioma | Immunotherapy
Rotavirus vaccine and anti-CTLA-4: a dynamic duo
Reduce, Reuse, Recycle to improve anti-CTLA-4 therapy
Mechanism of action of anti-PD-1, anti-PD-L1, and anti-CTLA4.... | Download Scientific Diagram
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody | PNAS
Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response - ScienceDirect
CTLA-4 Antibody (F-8) | SCBT - Santa Cruz Biotechnology
Immunothérapie dans les cancers digestifs – FMC-HGE
CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours | Nature
Mechanisms of action of CTLA-4 and CTLA-4 inhibitors (ipilimumab) A)... | Download Scientific Diagram
Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action - Willsmore - 2021 - European Journal of Immunology - Wiley Online Library
Mechanism of CTLA 4 and PD-1/PD-L1 inhibition. The activation of T... | Download Scientific Diagram
Frontiers | CTLA-4 and PD-1 Control of T-Cell Motility and Migration: Implications for Tumor Immunotherapy
Uncoupling therapeutic from immunotherapy-related adverse effects for safer and effective anti-CTLA-4 antibodies in CTLA4 humanized mice | Cell Research
